Details of the Drug

General Information of Drug (ID: DM5XRMA)

Drug Name
Tipapkinogene sovacivec
Indication
Disease Entry ICD 11 Status REF
Cervical Intraepithelial neoplasia 2E66.1 Phase 2 [1]
Cross-matching ID
UNII
P34L5Y2SR5
DrugBank ID
DB06239
TTD ID
D0P9QW

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human papillomavirus protein E6 (HPV E6) TTE2N95 VE6_HPV16 Modulator [2]
Human papillomavirus protein E7 (HPV E7) TT3CPZW VE7_HPV16 Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01022346) A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection. U.S. National Institutes of Health.
2 Immune therapy for human papillomaviruses-related cancers